BCYC - BICYCLE THERAPEUTICS plc

QQQ $ 448.04 $ 9.38 (2.14 %)

DIA $ 394.16 $ 4.59 (1.18 %)

SPY $ 530.14 $ 6.03 (1.15 %)

TLT $ 95.03 $ -0.93 (-0.97 %)

GLD $ 224.01 $ 1.28 (0.57 %)

Previous Close

$ 22.55

Open

$ 22.25

Bid

$ 22.65 x 100

Ask

-- x --

Day's Range

$ 22.14 - $ 22.74

52 Week Range

$ 12.54 - $ 27.24

Volume

345,410

Average Volume

Market Cap

1.17B

Beta (5Y Monthly)

$ 1.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-20-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-10-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

The Latest Analyst Ratings For Bicycle The...
08/07/2024 21:00:17

HC Wainwright & Co. Reiterates Buy on Bicy...
08/07/2024 20:17:14

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

Oppenheimer Maintains Outperform on Bicycl...
08/07/2024 18:01:08

Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and maintains $48 price target.

5Needham Reiterates Buy on Bicycle Therape...
08/07/2024 10:39:02

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

B. Riley Securities Downgrades Bicycle The...
08/07/2024 09:55:23

B. Riley Securities analyst Kalpit Patel downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Buy to Neutral and lowers the pr...

Bicycle Therapeutics Q2 2024 GAAP EPS $(0....
08/06/2024 12:00:30

Bicycle Therapeutics Filed A Prospectus Su...
06/18/2024 20:23:42

- SEC Filing

dow-dips-over-550-points-bjs-wholesale-club-earnings-beat-views

Dow Dips Over 550 Points; BJ's Wholesale C...
05/23/2024 18:40:33

gold-falls-sharply-us-composite-pmi-surges-in-may

Gold Falls Sharply; US Composite PMI Surge...
05/23/2024 16:01:36

elf-beauty-posts-upbeat-earnings-joins-nvidia-liveramp-holdings-borr-drilling-and-other-big-stocks-moving-higher-on-thursday

e.l.f. Beauty Posts Upbeat Earnings, Joins...
05/23/2024 14:26:28

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 12:06:48

Bicycle Therapeutics Reports $555M Private...
05/23/2024 11:16:44

The company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and se...

HC Wainwright & Co. Reiterates Buy on Bicy...
05/03/2024 19:20:12

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

Bicycle Therapeutics' Cash And Cash Equiva...
05/02/2024 11:53:41

Bicycle Therapeutics Q1 2024 GAAP EPS $(0....
05/02/2024 11:53:23

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of ...

Expert Ratings For Bicycle Therapeutics
04/10/2024 12:01:39

Needham Reiterates Buy on Bicycle Therapeu...
04/10/2024 09:22:53

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $43 price target.

Walmart To Rally Around 18%? Here Are 10 T...
02/21/2024 18:45:18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Canaccord Genuity Reiterates Buy on Bicycl...
02/21/2024 13:57:01

Canaccord Genuity analyst Bill Maughan reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $60 price target.

The Analyst Landscape: 4 Takes On Bicycle ...
02/21/2024 13:00:23